Interestingly, we identified 13 ACC targets in CDDI, from which 12 are found in our multi-omics signature, including DICER1 and KRAS as specific ACC biomarkers that were identified using systems biology tools. The gene discussed is KRAS; the disease is adrenal cortex carcinoma.